260 related articles for article (PubMed ID: 32511068)
1. Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective.
Bhattacharyya GS; Doval DC; Desai CJ; Chaturvedi H; Sharma S; Somashekhar SP
JCO Glob Oncol; 2020 Jun; 6():789-798. PubMed ID: 32511068
[TBL] [Abstract][Full Text] [Related]
2. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study.
Stavridi F; Kalogeras KT; Pliarchopoulou K; Wirtz RM; Alexopoulou Z; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Koutras A; Lazaridis G; Christodoulou C; Pentheroudakis G; Laskarakis A; Arapantoni-Dadioti P; Batistatou A; Sotiropoulou M; Aravantinos G; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
PLoS One; 2016; 11(10):e0164013. PubMed ID: 27695115
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers.
Gouri A; Benarba B; Dekaken A; Aoures H; Benharkat S
Curr Drug Targets; 2020; 21(10):1008-1025. PubMed ID: 32164510
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
8. Local-regional breast cancer recurrence: prognostic groups based on patterns of failure.
Moran MS; Haffty BG
Breast J; 2002; 8(2):81-7. PubMed ID: 11896752
[TBL] [Abstract][Full Text] [Related]
9. Molecular predictors of local tumor control in early-stage breast cancer.
Miyamoto DT; Harris JR
Semin Radiat Oncol; 2011 Jan; 21(1):35-42. PubMed ID: 21134652
[TBL] [Abstract][Full Text] [Related]
10. Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care.
Mukhtar RA; Wong JM; Esserman LJ
J Natl Compr Canc Netw; 2015 Jun; 13(6):737-43. PubMed ID: 26085389
[TBL] [Abstract][Full Text] [Related]
11. The influence of young age on outcome in early stage breast cancer.
Fowble BL; Schultz DJ; Overmoyer B; Solin LJ; Fox K; Jardines L; Orel S; Glick JH
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):23-33. PubMed ID: 8083119
[TBL] [Abstract][Full Text] [Related]
12. A multiple breast cancer stem cell model to predict recurrence of T
Qiu Y; Wang L; Zhong X; Li L; Chen F; Xiao L; Liu F; Fu B; Zheng H; Ye F; Bu H
BMC Cancer; 2019 Jul; 19(1):729. PubMed ID: 31340763
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermia and radiation therapy of local-regional recurrent breast cancer: prognostic factors for response and local control of diffuse or nodular tumors.
Kapp DS; Barnett TA; Cox RS; Lee ER; Lohrbach A; Fessenden P
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1147-64. PubMed ID: 2022519
[TBL] [Abstract][Full Text] [Related]
15. Over surgery in breast cancer.
MacNeill F; Karakatsanis A
Breast; 2017 Feb; 31():284-289. PubMed ID: 27894703
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of vascular endothelial growth factor as a prognostic marker for local relapse in early-stage breast cancer patients treated with breast-conserving therapy.
Moran MS; Yang Q; Goyal S; Harris L; Chung G; Haffty BG
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1236-43. PubMed ID: 21093162
[TBL] [Abstract][Full Text] [Related]
17. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
18. Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial.
Zhang X; Gunda A; Kranenbarg EM; Liefers GJ; Savitha BA; Shrivastava P; Serkad CPVK; Kaur T; Eshwaraiah MS; Tollenaar RAEM; van de Velde CJH; Seynaeve CMJ; Bakre M; Kuppen PJK
Breast Cancer Res; 2023 Apr; 25(1):40. PubMed ID: 37060036
[TBL] [Abstract][Full Text] [Related]
19. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
[TBL] [Abstract][Full Text] [Related]
20. MammaPrint Reduces Breast Cancer Overtreatment.
Cancer Discov; 2016 Jun; 6(6):OF4. PubMed ID: 27095361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
